Tapewire

Nasdaq · USD

IMVT

Immunovant, Inc.

Export transactions ↓
Tapewire entity
3632
SEC CIK
0001764013
Parsed reports
357

Last 12 months

Inside the activity.

1 purchase rows · 60 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202516
Jan 202603
Feb 202603
Mar 202601
Apr 202608
May 202607
Jun 2026010
Jul 2026012
Aug 202602
Sep 202601
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2022 Filed Aug 19, 2022 20:39 UTC
Torti FrankDirector
GrantStock Option (right to buy) · Derivative 339,296 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000089 · wf-form4_166094156090925.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,296

Underlying: Common Stock · 339,296 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:39 UTC
Torti FrankDirector
GrantCommon Stock 225,632 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000089 · wf-form4_166094156090925.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,358

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 11:38 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 510 $4.27 $2,177.70
Disclosure

SEC source: 0001764013-22-000078 · wf-form4_165909471978803.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,104

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 11:36 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 1,528 $4.27 $6,524.56
Disclosure

SEC source: 0001764013-22-000077 · wf-form4_165909456363894.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 552,731

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
July 22, 2022 Filed Jul 26, 2022 07:35 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 322 $4.70 $1,513.40
Disclosure

SEC source: 0001764013-22-000074 · wf-form4_165883529608492.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,626

F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 1,167 of these RSUs vested on July 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 11:05 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 1,376 $4.02 $5,531.52
Disclosure

SEC source: 0001764013-22-000072 · wf-form4_165667352814683.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 554,259

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on June 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 - $4.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 11:04 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 460 $4.02 $1,849.20
Disclosure

SEC source: 0001764013-22-000071 · wf-form4_165667344261552.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,614

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,136 of these RSUs vested on June 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 - $4.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 24, 2022 Filed May 25, 2022 20:26 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 492 $3.79 $1,864.68
Disclosure

SEC source: 0001764013-22-000047 · wf-form4_165351034511810.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,074

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on May 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.79 - $3.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 24, 2022 Filed May 25, 2022 20:23 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 1,471 $3.79 $5,575.09
Disclosure

SEC source: 0001764013-22-000045 · wf-form4_165351019453934.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,635

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on May 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.79 - $3.82 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 27, 2022 Filed Apr 29, 2022 11:08 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 541 $4.72 $2,553.52
Disclosure

SEC source: 0001764013-22-000043 · wf-form4_165123049662918.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,566

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 - $4.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 27, 2022 Filed Apr 29, 2022 11:05 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 1,622 $4.72 $7,655.84
Disclosure

SEC source: 0001764013-22-000041 · wf-form4_165123029015521.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 557,106

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
April 19, 2022 Filed Apr 20, 2022 16:34 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 1,392 $4.98 $6,932.16
Disclosure

SEC source: 0001764013-22-000039 · wf-form4_165048683626750.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,948

F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 25% of these RSUs vested on April 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
March 24, 2022 Filed Apr 14, 2022 11:18 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 6,381 $5.90 $37,647.90
Disclosure

SEC source: 0001764013-22-000037 · wf-form4_164993512439127.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,107

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 25% of these RSUs vested on March 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
March 24, 2022 Filed Apr 14, 2022 11:16 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 19,227 $5.90 $113,439.30
Disclosure

SEC source: 0001764013-22-000035 · wf-form4_164993497408514.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558,728

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 25% of these RSUs vested on March 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
January 28, 2022 Filed Jan 31, 2022 22:01 UTC
Levine Mark S.Chief Legal Officer
GrantStock Option (right to buy) · Derivative 383,000 $0.00 Strike: $6.72 $0.00
Disclosure

SEC source: 0001764013-22-000027 · wf-form4_164366644858148.xml · derivative · entry 2

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 383,000

Underlying: Common Stock · 383,000 shares

Expires 2032-01-28

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on January 19, 2023 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 28, 2022 Filed Jan 31, 2022 22:01 UTC
Levine Mark S.Chief Legal Officer
GrantCommon Stock 143,000 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000027 · wf-form4_164366644858148.xml · nonDerivative · entry 1

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,000

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on January 19, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:03 UTC GrantStock Option (right to buy) · Derivative 71,492 $0.00 Strike: $7.94 $0.00
Disclosure

SEC source: 0001764013-22-000019 · wf-form4_164202501508435.xml · derivative · entry 2

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,792

Underlying: Common Stock · 71,492 shares

Expires 2032-01-10

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:03 UTC GrantCommon Stock 21,726 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000019 · wf-form4_164202501508435.xml · nonDerivative · entry 1

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,926

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:13 UTC
Torti FrankDirector
GrantStock Option (right to buy) · Derivative 329,485 $0.00 Strike: $7.94 $0.00
Disclosure

SEC source: 0001764013-22-000023 · wf-form4_164202558772198.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 554,748

Underlying: Common Stock · 329,485 shares

Expires 2032-01-10

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:13 UTC
Torti FrankDirector
GrantCommon Stock 100,126 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000023 · wf-form4_164202558772198.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,726

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:09 UTC GrantStock Option (right to buy) · Derivative 71,492 $0.00 Strike: $7.94 $0.00
Disclosure

SEC source: 0001764013-22-000021 · wf-form4_164202534055827.xml · derivative · entry 2

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,973

Underlying: Common Stock · 71,492 shares

Expires 2032-01-10

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:09 UTC GrantCommon Stock 21,726 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000021 · wf-form4_164202534055827.xml · nonDerivative · entry 1

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,426

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:00 UTC GrantStock Option (right to buy) · Derivative 71,492 $0.00 Strike: $7.94 $0.00
Disclosure

SEC source: 0001764013-22-000017 · wf-form4_164202480829515.xml · derivative · entry 2

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,973

Underlying: Common Stock · 71,492 shares

Expires 2032-01-10

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 22:00 UTC GrantCommon Stock 21,726 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000017 · wf-form4_164202480829515.xml · nonDerivative · entry 1

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,173

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 21:56 UTC
Pande AtulDirector
GrantStock Option (right to buy) · Derivative 71,492 $0.00 Strike: $7.94 $0.00
Disclosure

SEC source: 0001764013-22-000015 · wf-form4_164202456711747.xml · derivative · entry 3

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,973

Underlying: Common Stock · 71,492 shares

Expires 2032-01-10

F4 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 21:56 UTC
Pande AtulDirector
GrantCommon Stock 21,726 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000015 · wf-form4_164202456711747.xml · nonDerivative · entry 1

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,926

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
January 07, 2022 Filed Jan 11, 2022 15:58 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 55,318 $7.25 $401,055.50
Disclosure

SEC source: 0001764013-22-000013 · wf-form4_164191666614109.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,488

F1 · security: On August 3, 2021, the holder was granted 285,306 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on August 4, 2021, of which 50% of these RSUs vested on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs.

Read SEC document
January 07, 2022 Filed Jan 11, 2022 15:53 UTC
Barnett Eva ReneeChief Financial Officer
SaleCommon Stock 29,959 $7.25 $217,202.75
Disclosure

SEC source: 0001764013-22-000011 · wf-form4_164191639600365.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,541

F1 · security: On October 4, 2021, the holder was granted 59,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 5, 2021. These RSUs vested in their entirety on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.

Read SEC document
January 07, 2022 Filed Jan 11, 2022 15:49 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 125,158 $7.25 $907,395.50
Disclosure

SEC source: 0001764013-22-000009 · wf-form4_164191616856320.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 577,955

F1 · security: On August 3, 2021, the holder was granted 570,613 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on August 4, 2021, of which 37.5% of these RSUs vested on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 12:39 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 26,813 $8.28 $222,011.64
Disclosure

SEC source: 0001764013-22-000004 · wf-form4_164157712900393.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,340

F1 · security: On June 11, 2021, the holder was granted 93,371 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021. These RSUs vested in their entirety on December 31, 2021. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.

Read SEC document
November 05, 2021 Filed Nov 9, 2021 14:09 UTC
Macias William L.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 167,325 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001764013-21-000121 · wf-form4_163648493233700.xml · derivative · entry 2

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,325

Underlying: Common Stock · 167,325 shares

Expires 2031-11-05

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 25, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
November 05, 2021 Filed Nov 9, 2021 14:09 UTC
Macias William L.Chief Medical Officer
GrantCommon Stock 112,108 $0.00 $0.00
Disclosure

SEC source: 0001764013-21-000121 · wf-form4_163648493233700.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,153

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of such date.

Read SEC document
October 15, 2021 Filed Oct 18, 2021 21:11 UTC
Barnett Eva ReneeChief Financial Officer
GrantStock Option (right to buy) · Derivative 333,000 $0.00 Strike: $8.72 $0.00
Disclosure

SEC source: 0001764013-21-000108 · wf-form4_163459145674723.xml · derivative · entry 2

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,000

Underlying: Common Stock · 333,000 shares

Expires 2031-10-15

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 4, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
October 15, 2021 Filed Oct 18, 2021 21:11 UTC
Barnett Eva ReneeChief Financial Officer
GrantCommon Stock 143,000 $0.00 $0.00
Disclosure

SEC source: 0001764013-21-000108 · wf-form4_163459145674723.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,500

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on October 4, 2022 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
October 04, 2021 Filed Oct 5, 2021 16:07 UTC
Barnett Eva ReneeChief Financial Officer
GrantCommon Stock 59,500 $0.00 $0.00
Disclosure

SEC source: 0001764013-21-000106 · wf-form4_163345002882992.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,500

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety on January 1, 2022, subject to the Reporting Person providing continuous service to the Issuer as of such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 19:59 UTC
Salzmann PeterDirector · Chief Executive Officer
Disposition to issuerStock Option (right to buy) · Derivative 464,700 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 4

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 464,700 shares

Expires 2031-03-19

F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 19:59 UTC
Salzmann PeterDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 464,700 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 3

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 464,700

Underlying: Common Stock · 464,700 shares

Expires 2031-03-19

F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 19:59 UTC
Salzmann PeterDirector · Chief Executive Officer
Disposition to issuerStock Option (right to buy) · Derivative 430,700 $0.00 Strike: $19.01 $0.00
Disclosure

SEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 2

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 430,700 shares

Expires 2030-05-14

F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 19:59 UTC
Salzmann PeterDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 430,700 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001764013-21-000095 · wf-form4_163164954372889.xml · derivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 430,700

Underlying: Common Stock · 430,700 shares

Expires 2030-05-14

F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 20:02 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
Disposition to issuerStock Option (right to buy) · Derivative 191,100 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 4

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 191,100 shares

Expires 2031-03-19

F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 20:02 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantStock Option (right to buy) · Derivative 191,100 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 3

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,100

Underlying: Common Stock · 191,100 shares

Expires 2031-03-19

F2 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 20:02 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
Disposition to issuerStock Option (right to buy) · Derivative 319,700 $0.00 Strike: $19.01 $0.00
Disclosure

SEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 2

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 319,700 shares

Expires 2030-05-14

F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 14, 2021 20:02 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantStock Option (right to buy) · Derivative 319,700 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001764013-21-000096 · wf-form4_163164971107075.xml · derivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,700

Underlying: Common Stock · 319,700 shares

Expires 2030-05-14

F1 · derivative.exercise_date: 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 16, 2021 17:15 UTC
Macias William L.Chief Medical Officer
Disposition to issuerStock Option (right to buy) · Derivative 369,320 $0.00 Strike: $10.71 $0.00
Disclosure

SEC source: 0001764013-21-000100 · wf-form4_163182692972092.xml · derivative · entry 2

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 369,320 shares

Expires 2031-06-11

F1 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 13, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
September 11, 2021 Filed Sep 16, 2021 17:15 UTC
Macias William L.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 369,320 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001764013-21-000100 · wf-form4_163182692972092.xml · derivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,320

Underlying: Common Stock · 369,320 shares

Expires 2031-06-11

F1 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 13, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 27, 2021 Filed Aug 30, 2021 13:08 UTC PurchaseCommon Stock 18,247 $8.24 $150,355.28
Disclosure

SEC source: 0001764013-21-000092 · wf-form4_163032892005129.xml · nonDerivative · entry 1

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,447

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.22 - $8.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 20, 2021 Filed Aug 20, 2021 22:14 UTC PurchaseCommon Stock 7,000 $7.65 $53,550.00
Disclosure

SEC source: 0001764013-21-000090 · wf-form4_162949763817516.xml · nonDerivative · entry 1

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,200

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 - $7.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 21:29 UTC
Pande AtulDirector
PurchaseCommon Stock 5,000 $7.98 $39,900.00
Disclosure

SEC source: 0001764013-21-000088 · wf-form4_162914934479727.xml · nonDerivative · entry 1

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Purchased through Trust Owned by Atul Pande and his Spouse

Disclosed balance after: 45,200

Read SEC document
August 10, 2021 Filed Aug 11, 2021 18:12 UTC PurchaseCommon Stock 5,500 $7.90 $43,450.00
Disclosure

SEC source: 0001764013-21-000081 · wf-form4_162870554557188.xml · nonDerivative · entry 1

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,700

Read SEC document
August 03, 2021 Filed Aug 4, 2021 20:10 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantCommon Stock 285,306 $0.00 $0.00
Disclosure

SEC source: 0001764013-21-000069 · wf-form4_162810780822330.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,806

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: 50% of the RSUs will vest on January 1, 2022 and the remainder of the RSUs will vest on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.